Baxter International Inc

詳細情報 Baxter International Inc 企業名

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

企業情報

企業コードBAX

会社名Baxter International Inc

上場日May 15, 1961

最高経営責任者「CEO」Mr. Andrew P. Hider

従業員数38000

証券種類Ordinary Share

決算期末May 15

本社所在地One Baxter Parkway

都市DEERFIELD

証券取引所NYSE Consolidated

国United States of America

郵便番号60015

電話番号12249482000

ウェブサイトhttps://www.baxter.com/

企業コードBAX

上場日May 15, 1961

最高経営責任者「CEO」Mr. Andrew P. Hider

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Andrew P. Hider

President, Chief Executive Officer, Director

368.05K

--

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

127.11K

-2.45%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

101.60K

-14.01%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

35.70K

+25.18%

Ms. Catherine R. (Cathy) Smith

Independent Director

30.23K

+31.17%

Ms. Patricia B. (Patty) Morrison

Independent Director

22.94K

+45.58%

Mr. Stephen H. (Steve) Rusckowski

Independent Director

16.45K

+77.49%

Mr. Jeffrey A. (Jay) Craig

Independent Director

10.65K

+206.88%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Andrew P. Hider

President, Chief Executive Officer, Director

368.05K

--

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

127.11K

-2.45%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

101.60K

-14.01%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

35.70K

+25.18%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

事業別USD

会社名

収益

比率

Infusion Therapies and Technologies

994.00M

37.87%

Care and Connectivity Solutions

427.00M

16.27%

Injectables and Anesthesia

335.00M

12.76%

Front Line Care

277.00M

10.55%

Advanced Surgery

268.00M

10.21%

他の

324.00M

12.34%

地域別USD

会社名

収益

比率

United States

1.49B

56.76%

International

1.14B

43.24%

事業別

地域別

事業別USD

会社名

収益

比率

Infusion Therapies and Technologies

994.00M

37.87%

Care and Connectivity Solutions

427.00M

16.27%

Injectables and Anesthesia

335.00M

12.76%

Front Line Care

277.00M

10.55%

Advanced Surgery

268.00M

10.21%

他の

324.00M

12.34%

株主

更新時刻: Tue, Aug 19

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

12.06%

Pzena Investment Management, LLC

10.80%

Dodge & Cox

10.15%

BlackRock Institutional Trust Company, N.A.

5.81%

State Street Global Advisors (US)

4.27%

他の

56.91%

株主統計

比率

The Vanguard Group, Inc.

12.06%

Pzena Investment Management, LLC

10.80%

Dodge & Cox

10.15%

BlackRock Institutional Trust Company, N.A.

5.81%

State Street Global Advisors (US)

4.27%

他の

56.91%

種類

株主統計

比率

Investment Advisor/Hedge Fund

46.91%

Investment Advisor

44.25%

Hedge Fund

3.20%

Research Firm

2.06%

Pension Fund

1.76%

Insurance Company

1.45%

Bank and Trust

1.29%

Sovereign Wealth Fund

1.14%

Individual Investor

0.46%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

1877

507.74M

98.85%

-23.16M

2025Q1

1934

508.09M

99.01%

-37.41M

2024Q4

1984

501.11M

97.98%

-41.68M

2024Q3

2005

485.40M

95.14%

-42.32M

2024Q2

2042

472.72M

92.77%

-47.98M

2024Q1

2091

469.13M

92.11%

-57.76M

2023Q4

2137

471.69M

92.98%

-44.04M

2023Q3

2123

465.39M

91.91%

-35.52M

2023Q2

2140

458.55M

90.66%

-30.65M

2023Q1

2123

459.27M

90.86%

-22.24M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

60.82M

11.85%

+290.58K

+0.48%

Mar 31, 2025

Pzena Investment Management, LLC

36.77M

7.17%

+3.13M

+9.32%

Mar 31, 2025

Dodge & Cox

51.46M

10.03%

-122.48K

-0.24%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

30.27M

5.9%

+743.24K

+2.52%

Mar 31, 2025

State Street Global Advisors (US)

21.77M

4.24%

-21.20K

-0.10%

Mar 31, 2025

T. Rowe Price Associates, Inc.

19.57M

3.81%

+4.32M

+28.32%

Mar 31, 2025

BlackRock Financial Management, Inc.

17.99M

3.51%

+419.98K

+2.39%

Mar 31, 2025

Geode Capital Management, L.L.C.

12.56M

2.45%

+109.37K

+0.88%

Mar 31, 2025

Harris Associates L.P.

9.00M

1.75%

+540.70K

+6.39%

Mar 31, 2025

BlackRock Investment Management, LLC

6.99M

1.36%

+2.18M

+45.23%

Mar 31, 2025

詳細を見る

関連ETF

更新時刻: Sat, Aug 2

銘柄名

比率

Cullen Enhanced Equity Income ETF

2.77%

iShares Large Cap Value Active ETF

2.32%

First Trust Indxx Medical Devices ETF

1.96%

iShares U.S. Medical Devices ETF

1.77%

SPDR S&P Health Care Equipment ETF

1.76%

North Shore Equity Rotation ETF

1.68%

Invesco S&P 500 Equal Weight Health Care ETF

1.6%

VanEck Morningstar SMID Moat ETF

1.2%

Humankind US Stock ETF

0.96%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.81%

詳細を見る

Cullen Enhanced Equity Income ETF

比率2.77%

iShares Large Cap Value Active ETF

比率2.32%

First Trust Indxx Medical Devices ETF

比率1.96%

iShares U.S. Medical Devices ETF

比率1.77%

SPDR S&P Health Care Equipment ETF

比率1.76%

North Shore Equity Rotation ETF

比率1.68%

Invesco S&P 500 Equal Weight Health Care ETF

比率1.6%

VanEck Morningstar SMID Moat ETF

比率1.2%

Humankind US Stock ETF

比率0.96%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

比率0.81%

配当金

過去5年間の配当金総支払額は 2.75B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Feb 11, 2025

BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option

Feb 28, 2025

Apr 01, 2025

Feb 28, 2025

Nov 11, 2024

BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option

Nov 29, 2024

Jan 02, 2025

Nov 29, 2024

Jul 16, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option

Aug 30, 2024

Oct 01, 2024

Aug 30, 2024

May 07, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option

May 31, 2024

Jul 01, 2024

May 31, 2024

Feb 12, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

Nov 14, 2023

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option

Dec 01, 2023

Jan 02, 2024

Nov 30, 2023

Jul 18, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option

Sep 01, 2023

Oct 02, 2023

Aug 31, 2023

May 01, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023

Jun 02, 2023

Jul 03, 2023

Jun 01, 2023

Feb 14, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option

Feb 24, 2023

Apr 03, 2023

Feb 23, 2023

Nov 15, 2022

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022

Dec 02, 2022

Jan 03, 2023

Dec 01, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

21.980USD

Baxter International Inc

21.980

概要

企業名

金融

分析